CHRONIC PELVIC PAIN
- Autores: KUZNETSOVA I.V1
-
Afiliações:
- I.M. Sechenov First Moscow State Medical University
- Edição: Nº 5 (2013)
- Páginas: 91-97
- Seção: Articles
- URL: https://journals.eco-vector.com/0300-9092/article/view/246977
- ID: 246977
Citar
Texto integral
Acesso aberto
Acesso está concedido
Acesso é pago ou somente para assinantes
Resumo
Chronic pelvic pain syndrome is one of the urgent problems of modern gynecology and therapy for the pain syndrome should be based on its pathogenetic features, which in full measure holds true for gynecological practice. According to the published European guidelines, the management of chronic pelvic pain should be approached in a comprehensive manner; moreover, the basic stage of its therapy is the use of nonsteroidal anti-inflammatory drugs (NSAIDs) just on the first days of pain. NSAID is an effective agent for the pathogenetic therapy of acute or chronic pain and cyclooxygenase-2 inhibitors are novel promising therapeutic targets. Analysis of trials calls for their incorporation into a package of measures taken to treat patients with pelvic pain symptoms.
Palavras-chave
Texto integral
Bibliografia
- Воробьева О.В. Хронические тазовые боли: фокус на миофасциальный болевой синдром мышц тазового дна. Consilium medicum. 2012: 6(14): 14-8.
- Яроцкая Е.Л., Адамян Л.В. Особенности тактики ведения гинекологических больных, страдающих тазовыми болями. Проблемы репродукции. 2003; 3: 17-26.
- Gunter J. Neurobiology of chronic pelvic pain. In: Potts J., ed. Genitourinary pain and inflammation. Totowa, New Jersey: Humana Press; 2008: 3-17.
- Taylor R.N. Endometriosis. In: Strauss III J.F., Barbieri R.L., eds. Yen and Jaffe’s reproductive endocrinology: physiology, pathophysiology, and clinical management. Philadelphia: Elsevier Saunders; 2004: 691-711.
- Sommer C, Kress M. Recent findings on how proinflammatory cytokines cause pain: peripheral mechanism in inflammatory and neurophatic hyperalgesia. Neurosci. Lett. 2004; 361: 184-7.
- Coosemans A., Moerman P., Vergote I., Koninckx P.R., Gool S.W.V., Amant F. Wilm's tumor gene 1(WT1) overexpression in neurons in deep endometriosis: a pilot study. Fertil. Steril. 2009; 91(4): 1441-4.
- Giamberardino M.A. Women and visceral pain: are the reproductive organs the main protagonists? Mini-review at the occasion of the “European week against pain in women 2007”. Eur. J. Pain. 2008; 12(3): 257-60.
- Quinn M. Obstetric denervation - gynaecological reinnervation: disruption of the inferior hypogastric plexsus in childbirth as a source of gynecological symptoms. Med. Hypotheses. 2004; 63(3): 390-3.
- Wiech K., Tracey I. Influence of negative emotions on pain: behavioral effects and neural mechanisms. Neuroimage. 2009; 47: 987-94.
- Yarell J., Giamberardino M.A., Robert M., Nasr-Esfabani M. Bed-side testing for chronic pelvic pain: discriminating visceral from somatic pain. Pain Res. Treat. 2011; 11: 692-8.
- Подзолкова Н.М., Глазкова О.Л. Симптом. Синдром. Диагноз. Дифференциальная диагностика в гинекологии. 2-е изд. М.: ГЭОТАР-Медиа; 2005. 250 c.
- Missmer S.A., Cramer D.W. The epidemiology of endometriosis. Obstet. Gynecol. Clin. North Am. 2003; 30: 1-19.
- Giudice L.C., Kao L.C. Endometriosis. Lancet. 2004; 364: 1789-99.
- Howard F.M. Chronic pelvic pain. Obstet. Gynecol. 2003; 101: 594-611.
- Cheong Y., William Stones R. Chronic pelvic pain: aetiology and therapy. Best Pract. Res. Clin. Obstet. Gynaecol. 2006; 20(5): 695-711.
- Howard F.M. The role of laparoscopy in the chronic pelvic pain patient. Clin. Obstet. Gynecol. 2003; 46: 749-66.
- Craig K.D., Versloot J., Goubert L., Vervoort T., Crombez G. Perceiving pain in others: automatic and controlled mechanisms. J. Pain. 2010; 11(2): 101-8.
- Насонов Е.Л., Лазебник Л.Б., Беленков Ю.Н. и др. Применение нестероидных противовоспалительных препаратов. Клинические рекомендации. М.: Алмаз; 2006: 15-22.
- Каратеев А.Е., Яхно Н.Н., Лазебник Л.Б., Кукушкин М.Л., Дроздов В.Н., Исаков В.А., Насонов Е.Л. Применение нестероидных противовоспалительных препаратов. Клинические рекомендации. М.: ИМА-ПРЕСС; 2009: 9.
- Matsuzaki S., Canis M., Pouly J.L., Botchorishvili R., Dechelotte P.J., Mage G. Both GnRH agonist and continuous oral progestin treatments reduce the expression of the tyrosine kinase receptor B and mu-opioid receptor in deep infiltrating endometriosis. Hum. Reprod. 2007; 22(1): 124-8.
- American College of Obstetricians and Gynecologists Committee on Practice Bulletins-Gynecology. ACOG Practice Bulletin No. 51: chronic pelvic pain. Obstet. Gynecol. 2004; 103(3): 589-605.
- Тихомиров А.Л., Лубнин Д.М. Патогенетическое обоснование применения агонистов ГнРГ в терапии сочетанной гинекологической патологии. Вопросы гинекологии, акушерства и перинатологии. 2006; 5(1): 82-7.
- Prentice A., Deary A.J., Bland E. Progestagens and antiprogestagens for pain associated with endometriosis. Cochrane Database Syst. Rev. 2000; (2): CD002122.
- Vercellini P., Pietropaolo G., Di Georgi O., Pasin R., Chiodini A., Crosignani P.G. Treatment of symptomatic rectovaginal endometriosis with an estrogen-progestogen combination versus low-dose norethindrone acetate. Fertil. Steril. 2005; 84(5): 1375-87.
- Kennedy S.,Bergqvist A., Chapron C.,D’HoogheT., Dunselman G., Greb R. et al. ESHRE guideline for the diagnosis and treatment of endometriosis. Hum. Reprod. 2005; 20(10): 2698-704.
Arquivos suplementares
